Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogen (NEOG) Gains from Sales and Divestitures (2022 - 2025)

Neogen (NEOG) has 4 years of Gains from Sales and Divestitures data on record, last reported at $374000.0 in Q2 2025.

  • For Q2 2025, Gains from Sales and Divestitures rose 62.61% year-over-year to $374000.0; the TTM value through May 2025 reached $374000.0, up 62.61%, while the annual FY2025 figure was $374000.0, 62.61% up from the prior year.
  • Gains from Sales and Divestitures reached $374000.0 in Q2 2025 per NEOG's latest filing, up from $230000.0 in the prior quarter.
  • Across five years, Gains from Sales and Divestitures topped out at $374000.0 in Q2 2025 and bottomed at $25000.0 in Q2 2022.
  • Average Gains from Sales and Divestitures over 4 years is $172250.0, with a median of $145000.0 recorded in 2023.
  • Peak YoY movement for Gains from Sales and Divestitures: soared 283.33% in 2024, then surged 62.61% in 2025.
  • A 4-year view of Gains from Sales and Divestitures shows it stood at $25000.0 in 2022, then surged by 140.0% to $60000.0 in 2023, then skyrocketed by 283.33% to $230000.0 in 2024, then skyrocketed by 62.61% to $374000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Gains from Sales and Divestitures were $374000.0 in Q2 2025, $230000.0 in Q2 2024, and $60000.0 in Q2 2023.